Eris Lifesciences Limited — Updates, 25-08-2025: Press Release
25-08-2025 | 11:44 am
25-08-2025 | 11:44 am
Eris Lifesciences' Ahmedabad unit received ANVISA approval, enabling entry into Brazil, South America's largest pharmaceutical market. This operational milestone validates the company's manufacturing quality, significantly expanding its global market footprint.
No comments yet. Be the first to comment!
